| Cryptogenic stroke and underlying atrial fibrillation T Sanna, HC Diener, RS Passman, V Di Lazzaro, RA Bernstein, ... New England Journal of Medicine 370 (26), 2478-2486, 2014 | 2013 | 2014 |
| Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study GW Albers, VN Thijs, L Wechsler, S Kemp, G Schlaug, E Skalabrin, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 1454 | 2006 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013 | 1199 | 2013 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1155 | 2018 |
| VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death D Lambrechts, E Storkebaum, M Morimoto, J Del-Favero, F Desmet, ... Nature genetics 34 (4), 383-394, 2003 | 1091 | 2003 |
| MRI-guided thrombolysis for stroke with unknown time of onset G Thomalla, CZ Simonsen, F Boutitie, G Andersen, Y Berthezene, ... New England Journal of Medicine 379 (7), 611-622, 2018 | 1029 | 2018 |
| Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes R Malik, G Chauhan, M Traylor, M Sargurupremraj, Y Okada, A Mishra, ... Nature genetics 50 (4), 524-537, 2018 | 910 | 2018 |
| Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study WJ Schonewille, CAC Wijman, P Michel, CM Rueckert, C Weimar, ... The Lancet Neurology 8 (8), 724-730, 2009 | 772 | 2009 |
| Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke H Ma, BCV Campbell, MW Parsons, L Churilov, CR Levi, C Hsu, ... New England Journal of Medicine 380 (19), 1795-1803, 2019 | 672 | 2019 |
| The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial EC Sandset, PMW Bath, G Boysen, D Jatuzis, J Kõrv, S Lüders, ... The Lancet 377 (9767), 741-750, 2011 | 611 | 2011 |
| Tenecteplase versus alteplase before thrombectomy for ischemic stroke BCV Campbell, PJ Mitchell, L Churilov, N Yassi, TJ Kleinig, RJ Dowling, ... New England Journal of Medicine 378 (17), 1573-1582, 2018 | 572 | 2018 |
| Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies M Traylor, M Farrall, EG Holliday, C Sudlow, JC Hopewell, YC Cheng, ... The Lancet Neurology 11 (11), 951-962, 2012 | 560 | 2012 |
| Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy VN Thijs, GW Albers Neurology 55 (4), 490-498, 2000 | 423 | 2000 |
| Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke International Stroke Genetics Consortium (ISGC), ... Nature genetics 44 (3), 328-333, 2012 | 406 | 2012 |
| Optimal Tmax threshold for predicting penumbral tissue in acute stroke JM Olivot, M Mlynash, VN Thijs, S Kemp, MG Lansberg, L Wechsler, ... Stroke 40 (2), 469-475, 2009 | 405 | 2009 |
| Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke MG Lansberg, VN Thijs, MW O'Brien, JO Ali, AJ de Crespigny, DC Tong, ... American Journal of Neuroradiology 22 (4), 637-644, 2001 | 375 | 2001 |
| Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection S Debette, A Compter, MA Labeyrie, M Uyttenboogaart, TM Metso, ... The Lancet Neurology 14 (6), 640-654, 2015 | 361 | 2015 |
| Extending thrombolysis to 4· 5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data BCV Campbell, H Ma, PA Ringleb, MW Parsons, L Churilov, M Bendszus, ... The Lancet 394 (10193), 139-147, 2019 | 350 | 2019 |
| Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis MG Lansberg, E Bluhmki, VN Thijs Stroke 40 (7), 2438-2441, 2009 | 331 | 2009 |
| EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans A Van Hoecke, L Schoonaert, R Lemmens, M Timmers, KA Staats, ... Nature medicine 18 (9), 1418-1422, 2012 | 318 | 2012 |
Albers GWStanfordVerified email at stanford.edu
